Blue Jet Healthcare Limited Market Cap ($944.64 Million)
Market Cap & Net Worth: Blue Jet Healthcare Limited (BLUEJET)
Blue Jet Healthcare Limited market cap. Blue Jet Healthcare Limited (NSE:BLUEJET) has a market capitalization of $944.64 Million (Rs87.35 Billion) as of October 31, 2026. Listed on the NSE stock exchange, this India-based company holds position #8871 globally and #438 in its home market, demonstrating a 1.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Blue Jet Healthcare Limited's stock price Rs503.55 by its total outstanding shares 173465425 (173.47 Million).
Blue Jet Healthcare Limited Market Cap History (2023–2026)
Blue Jet Healthcare Limited market cap history from 2023 to 2026. Data shows growth from $689.22 Million to $944.64 Million (6.88% CAGR). Check Blue Jet Healthcare Limited stock price for real-time trading data and today's change.
Blue Jet Healthcare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Blue Jet Healthcare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see BLUEJET cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.10x
Blue Jet Healthcare Limited's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.38x
Blue Jet Healthcare Limited's market cap is 0.38 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $689.22 Million | $7.18 Billion | $1.60 Billion | 0.10x | 0.43x |
| 2024 | $1.06 Billion | $7.10 Billion | $1.64 Billion | 0.15x | 0.65x |
| 2025 | $994.64 Million | $10.30 Billion | $3.05 Billion | 0.10x | 0.33x |
| 2026 | $944.64 Million | $9.47 Billion | $2.48 Billion | 0.10x | 0.38x |
Competitor Companies of BLUEJET by Market Capitalization
Companies near Blue Jet Healthcare Limited in the global market cap rankings as of October 31, 2026. See net asset quality index of Blue Jet Healthcare Limited to understand what proportion of total assets are financed by equity.
Key companies related to Blue Jet Healthcare Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #183 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #374 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #422 globally with a market cap of $67.80 Billion USD ( AU$95.82 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #498 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #183 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $540.00 |
| #374 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $818.77 |
| #422 | CSL Ltd | AU:CSL | $67.80 Billion | AU$197.50 |
| #498 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $222.76 |
Market Capitalization of Blue Jet Healthcare Limited (2023–2026)
Market capitalization of Blue Jet Healthcare Limited from 2023 to today. Between 2023 and today, Blue Jet Healthcare Limited's market cap moved from $689.22 Million to $ 944.64 Million, with a yearly change of 6.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs944.64 Million | -5.03% |
| 2025 | Rs994.64 Million | -6.11% |
| 2024 | Rs1.06 Billion | +53.70% |
| 2023 | Rs689.22 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Blue Jet Healthcare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $944.64 Million USD |
| MoneyControl | $944.64 Million USD |
| MarketWatch | $944.64 Million USD |
| marketcap.company | $944.64 Million USD |
| Reuters | $944.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more